Andlauer Healthcare Group Inc. (TSE:AND - Get Free Report) has earned an average rating of "Moderate Buy" from the seven brokerages that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is C$48.57.
Several equities research analysts have recently commented on the company. Scotiabank upped their price objective on Andlauer Healthcare Group from C$43.00 to C$44.00 in a research note on Thursday, November 7th. TD Securities boosted their price target on Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the company a "buy" rating in a report on Thursday, November 7th.
Get Our Latest Stock Analysis on Andlauer Healthcare Group
Andlauer Healthcare Group Stock Performance
TSE AND traded down C$0.08 during trading hours on Friday, hitting C$43.25. 32,217 shares of the company's stock traded hands, compared to its average volume of 30,317. The company has a current ratio of 1.35, a quick ratio of 1.66 and a debt-to-equity ratio of 41.86. Andlauer Healthcare Group has a 52 week low of C$36.43 and a 52 week high of C$44.92. The firm has a market capitalization of C$808.78 million, a P/E ratio of 28.45 and a beta of 0.66. The business's fifty day moving average price is C$42.15 and its two-hundred day moving average price is C$40.22.
About Andlauer Healthcare Group
(
Get Free ReportAndlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Featured Articles
Before you consider Andlauer Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andlauer Healthcare Group wasn't on the list.
While Andlauer Healthcare Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.